SENSICARDIAC vs Acumen Hypotension Prediction Index (HPI) Feature Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

AI Verdict

SENSICARDIAC and Acumen HPI are adjacent tools within the broader Cardiology AI category, but they address distinct clinical problems. SENSICARDIAC focuses on the detection and classification of heart murmurs using acoustic data, aiding in cardiac diagnosis. In contrast, Acumen HPI is designed for predictive monitoring of hypotensive events using hemodynamic data, primarily for proactive critical care management.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your practice requires an efficient, AI-powered solution for remote heart murmur detection and classification, particularly for reducing unnecessary specialist referrals. This tool is ideal for primary care, internal medicine, or pediatric settings looking to integrate advanced cardiac screening with electronic stethoscopes and provide detailed, real-time diagnostic quality reports.

View SENSICARDIAC →

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) if your clinical environment demands proactive hemodynamic management to prevent hypotensive events in high-acuity settings. This software is best suited for anesthesiology, critical care, or emergency medicine where its machine learning algorithms can predict hypotension up to 15 minutes in advance, enabling timely intervention and improving patient outcomes.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	Acumen Hypotension Prediction Index (HPI) Feature Software
Deployment	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC (Tool A) offers a guided auscultation process and integrates with common electronic stethoscopes, suggesting a more intuitive and accessible workflow for general use. Its cloud and desktop deployment options also provide flexibility. Acumen HPI (Tool B) is integrated into a specific monitoring platform, which, while powerful, implies a more specialized and potentially steeper learning curve within that ecosystem.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI (Tool B) provides a first-of-its-kind predictive capability, alerting clinicians to hypotensive events up to 15 minutes before they occur, with demonstrated reductions in incidence, duration, and severity of intraoperative hypotension. This proactive intervention in critical care settings offers a higher immediate clinical value by preventing adverse events. SENSICARDIAC (Tool A) offers significant diagnostic aid for heart murmurs, but Acumen HPI's predictive nature for critical events gives it an edge in direct patient outcome impact.

Pricing & Value

Tie

Neither SENSICARDIAC (Tool A) nor Acumen HPI (Tool B) provides public pricing information, making it impossible to conduct a head-to-head comparison on cost or assess their relative value. Both require direct contact with the vendor for pricing details.

Enterprise Readiness

SENSICARDIAC

Both tools are HIPAA compliant and offer a BAA, essential for enterprise adoption. However, SENSICARDIAC (Tool A) offers flexible cloud and desktop deployment options, making it potentially easier to integrate into a wider range of existing IT infrastructures. Acumen HPI (Tool B) is integrated into a specific proprietary platform (Edwards Lifesciences HemoSphere), which might limit its readiness for enterprises not already invested in that ecosystem.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI (Tool B) stands out for its truly predictive capability, using machine learning to anticipate critical hypotensive events before they manifest, and providing insights into underlying hemodynamic factors. This represents a significant advancement from reactive monitoring to proactive intervention. While SENSICARDIAC (Tool A) innovates by applying AI to stethoscope diagnostics, Acumen HPI's predictive nature for a critical physiological event is a more profound leap in healthcare AI.

Support & Docs

Tie

The provided structured facts do not contain any information regarding the availability, quality, or channels for support and documentation for either SENSICARDIAC (Tool A) or Acumen HPI (Tool B). Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	Acumen Hypotension Prediction Index (HPI) Feature Software
Name	SENSICARDIAC	Acumen Hypotension Prediction Index (HPI) Feature Software
Company	DIACOUSTIC MEDICAL (PTY)	Edwards Lifesciences
Primary AI Function	AI-powered heart murmur detection and classification (pathological/physiological)	Machine learning for predictive analysis of blood pressure waveforms to detect and alert to hypotensive events
Specialties	Cardiology, Internal Medicine, Pediatrics	Anesthesiology, Critical Care, Emergency Medicine
Key Feature (Specific)	Classification of murmurs (Class I: dangerous pathological, Class III: innocent physiological), Detailed cardiac reports	Hypotension Prediction Index (HPI) parameter (0-100 score), Predicts hypotension up to 15 minutes before an event
Integration/Compatibility	Electronic stethoscopes (e.g., 3M Littmannu00ae 3200)	Edwards Lifesciences HemoSphere, invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and Acumen Hypotension Prediction Index (HPI) Feature Software.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into existing clinical workflows and what level of EHR integration is supported for data transfer and documentation?

SENSICARDIAC integrates with electronic stethoscopes and provides downloadable PDF cardiac reports, which can be manually incorporated into patient records. Acumen HPI is integrated directly into the Edwards Lifesciences HemoSphere advanced monitoring platform, suggesting a more embedded and automated data flow within that specific critical care ecosystem.

What is the reported accuracy or sensitivity of each tool in its specific clinical application, and how is this validated?

SENSICARDIAC classifies murmurs as pathological or physiological by analyzing against a large validated database of pathological heart murmurs. Acumen HPI uses machine learning to predict hypotension up to 15 minutes before an event, with demonstrated reductions in the incidence, duration, and severity of intraoperative hypotension, showing a specificity and sensitivity of 89% and 90% respectively in an internal validation.

For which specific patient populations or clinical scenarios is each tool most beneficial, considering their distinct specialties?

SENSICARDIAC is tailored for cardiology, internal medicine, and pediatrics, focusing on early heart murmur detection and classification to reduce unnecessary referrals. Acumen HPI is designed for anesthesiology, critical care, and emergency medicine, aiding in proactive hemodynamic management to prevent hypotensive events in high-acuity patients, including surgical and non-surgical patients receiving advanced hemodynamic monitoring.

What is the typical learning curve for a physician or clinical team to effectively utilize each tool, and how quickly can clinical value be realized?

SENSICARDIAC features a guided auscultation process and real-time analysis, suggesting a relatively intuitive integration into physical examination routines for quick value realization in murmur screening. Acumen HPI provides a clear HPI score, Smart Alerts, and a Relationship View, which may require some initial training to fully leverage for proactive hemodynamic management, especially given its integration into a complex monitoring platform.

What audit-trail capabilities does each tool offer for tracking data access and analysis, and what additional security measures are in place beyond standard compliance?

SENSICARDIAC provides detailed cardiac reports as downloadable PDFs, which can serve as a record of the analysis performed. Acumen HPI, being integrated into the HemoSphere platform, would rely on the platform's inherent data logging and security features, though specific additional measures beyond HIPAA are not detailed in the provided information.

What are the key considerations for deploying each tool across multiple clinical sites, and how might this impact implementation?

SENSICARDIAC's cloud-based service and integration with electronic stethoscopes suggest a potentially simpler multi-site rollout, primarily requiring device and cloud access setup at each location. Acumen HPI's deployment is integrated into the Edwards Lifesciences HemoSphere platform, meaning multi-site implementation would depend on the existing or planned HemoSphere infrastructure across facilities, and may require training and education for routine use.